GSA Capital Partners’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Sell |
15,675
-6,231
| -28% | -$87.5K | 0.02% | 1460 |
|
|
2025
Q1 | $343K | Buy |
+21,906
| New | +$343K | 0.03% | 1052 |
|
|
2024
Q4 | – | Sell |
-237,174
| Closed | -$2.21M | – | 1590 |
|
|
2024
Q3 | $2.21M | Buy |
237,174
+208,599
| +730% | +$1.94M | 0.17% | 97 |
|
|
2024
Q2 | $266K | Sell |
28,575
-7,973
| -22% | -$74.2K | 0.02% | 1330 |
|
|
2024
Q1 | $362K | Sell |
36,548
-38,306
| -51% | -$379K | 0.03% | 1096 |
|
|
2023
Q4 | $242K | Buy |
+74,854
| New | +$242K | 0.02% | 1225 |
|
|
2022
Q2 | – | Sell |
-27,851
| Closed | -$536K | – | 1383 |
|
|
2022
Q1 | $536K | Buy |
+27,851
| New | +$536K | 0.07% | 478 |
|